EUVIMEDEUVIMED entdecken
Crossref

Therapeutic personalisation I: practical aspects of pharmacokinetic monitoring

María Calvo Arbeloa

Boletín de Información Farmacoterapéutica de Navarra · 2025

DOI: 10.54095/bitn20253203en ↗

Kurz gefasst

Fachartikel in der Zeitschrift Boletín de Información Farmacoterapéutica de Navarra, 2025. Verfasst von María Calvo Arbeloa.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The main aim of clinical pharmacokinetics is to optimize pharmacotherapy. This requires an in-depth knowledge of the pharmacokinetic parameters and different population-based models. Its application requires a global vision that takes into account the state and clinical characteristics of the patient and the pharmacotherapeutic objectives. The most commonly monitored drugs are antimicrobial agents, digoxin, antiepileptics and immunosuppressants. Pharmacokinetic monitoring is particularly useful in specific populations or clinical situations, such as abnormal liver or kidney function, extreme ages or hypoalbuminaemia. Clinical pharmacokinetics units at hospitals are essential to ensure personalised medicine.

Zitieren

APA

Arbeloa, M. C. (2025). Therapeutic personalisation I: practical aspects of pharmacokinetic monitoring. Boletín de Información Farmacoterapéutica de Navarra. https://doi.org/10.54095/bitn20253203en

Vancouver

Arbeloa MC. Therapeutic personalisation I: practical aspects of pharmacokinetic monitoring. Boletín de Información Farmacoterapéutica de Navarra. 2025. doi:10.54095/bitn20253203en

BibTeX
@article{Arbeloa2025,
  author = {Arbeloa, María Calvo},
  title = {Therapeutic personalisation I: practical aspects of pharmacokinetic monitoring},
  journal = {Boletín de Información Farmacoterapéutica de Navarra},
  year = {2025},
  doi = {10.54095/bitn20253203en}
}
Kostenlos starten →